InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Dagnon Terry. Director active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 5 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €97k. History available since 3 December 2021. The latest transaction was disclosed on 21 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
10,000 shares@ US$1.050.036% mcap10.3% of flowCommon StockSEC:0001209191-22-038989:0
Ideal exit: 18 Mar 2023 (T+270)
25,201 shares@ US$1.380.11% mcap71.0% of flowCommon StockSEC:0001209191-21-068135
Ideal exit: 2 Sept 2022 (T+270)
25,201 shares@ US$1.380.11% mcap31.8% of flowCommon StockSEC:0001209191-21-068135:0
Ideal exit: 2 Sept 2022 (T+270)
10,000 shares@ US$1.420.046% mcap13.0% of flowCommon StockSEC:0001209191-21-067838:0
Ideal exit: 30 Aug 2022 (T+270)
10,000 shares@ US$1.420.046% mcap29.0% of flowCommon StockSEC:0001209191-21-067838
Ideal exit: 30 Aug 2022 (T+270)
5 of 5 declarations
About Dagnon Terry
Terry Dagnon is a director at Outlook Therapeutics, Inc.
